Dexamethasone and Neomycin sulfate and Polymyxin B sulfate ophthalmic ointment

 

Dexamethasone and Neomycin sulfate and Polymyxin B sulfate ophthalmic ointment, Sandoz
1 mg/1 gram- 3.5 mg/1 mg- 10,000 unit/1 gram, 3.5 gram tube, 1 count (NDC 61314-0631-36)

Reason for the Shortage

• Perrigo has dexamethasone/neomycin sulfate/polymyxin B sulfate ophthalmic ointment on shortage due to manufacturing issues.
• Sandoz has dexamethasone/neomycin sulfate/polymyxin B sulfate ophthalmic ointment on shortage due to increased demand.
• Valeant has dexamethasone/neomycin sulfate/polymyxin B sulfate ophthalmic ointment on shortage due to manufacturing delay.
  

Available Products

Maxitrol ophthalmic ointment, Alcon Labs
1 mg/1 gram - 3.5 mg/1 mg - 10,000 unit/1 gram, 3.5 gram tube, 1 count (NDC 00065-0631-36)

Estimated Resupply Dates

• Perrigo has dexamethasone/neomycin sulfate/polymyxin B sulfate ophthalmic ointment on back order and the company estimates a release date in early-November 2015.
• Sandoz has dexamethasone/neomycin sulfate/polymyxin B sulfate ophthalmic ointment on back order and the company estimates a release date in early-October 2015.
• Valeant has dexamethasone/neomycin sulfate/polymyxin B sulfate ophthalmic ointment on back order and the company estimates a release date in December 2015.

Related Shortages

• Cephalexin Oral Suspension — Resolved
• Chloramphenicol Sodium Succinate Injection — No Commercially Available Preparations
• Ofloxacin Otic Solution — Current
• Sulfacetamide and Prednisolone Ophthalmic Ointment — Resolved

Updated

September 30, 2015, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.